Consumer healthcare company Synergy CHC Corp has filed for listing on the Nasdaq. The stock currently trades on the Over-the-Counter Markets under the ticker symbol SNYR. If approved, the stock will trade on the Nasdaq under the same symbol.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $2.13 |
|---|---|
| 52-week range | $0.12 - $10.00 |
| 50-day moving average | $2.80 |
| 200-day moving average | $4.28 |
| Wall St. target price | $10.00 |
| PE ratio | 7.6071 |
| Dividend yield | N/A |
| Earnings per share (TTM) | $0.28 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $2.13 from 2025-05-02
| 1 week (2025-04-25) | 32.30% |
|---|---|
| 1 month (2025-04-04) | -7.19% |
| 3 months (2025-02-04) | -49.53% |
| 6 months (2024-10-31) | N/A |
| 1 year (2024-05-03) | 1,689.92% |
|---|---|
| 2 years (2023-05-03) | 615.97% |
| 3 years (2022-05-03) | 3,479.83% |
| 5 years (2020-05-01) | 297.76% |
Valuing Synergy CHC Corp stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Synergy CHC Corp's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Synergy CHC Corp's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 8x. In other words, Synergy CHC Corp shares trade at around 8x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
However, Synergy CHC Corp's P/E ratio is best considered in relation to those of others within the medical distribution industry or those of similar companies.
Synergy CHC Corp's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $5.9 million.
The EBITDA is a measure of a Synergy CHC Corp's overall financial performance and is widely used to measure a its profitability.
To put Synergy CHC Corp's EBITDA into context you can compare it against that of similar companies.
| Revenue TTM | $34.8 million |
|---|---|
| Operating margin TTM | 13.23% |
| Gross profit TTM | $23.6 million |
| Return on assets TTM | 25.37% |
| Return on equity TTM | -361.12% |
| Profit margin | 6.1% |
| Book value | $-1.95 |
| Market Capitalization | $18.3 million |
TTM: trailing 12 months
We're not expecting Synergy CHC Corp to pay a dividend over the next 12 months.
You may also wish to consider:
Synergy CHC Corp's shares were split on a 10:119 basis on 12 September 2024 . So if you had owned 119 shares the day before before the split, the next day you'd have owned 10 shares. This wouldn't directly have changed the overall worth of your Synergy CHC Corp shares – just the quantity. However, indirectly, the new 1090% higher share price could have impacted the market appetite for Synergy CHC Corp shares which in turn could have impacted Synergy CHC Corp's share price.
Over the last 12 months, Synergy CHC Corp's shares have ranged in value from as little as $0.119 up to $10. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Synergy CHC Corp's is 0.326. This would suggest that Synergy CHC Corp's shares are less volatile than average (for this exchange).
To put Synergy CHC Corp's beta into context you can compare it against those of similar companies.
Synergy CHC Corp. provides consumer health care, beauty, and lifestyle products in the United States, Canada, and the United Kingdom. It offers brain health nutritional supplements under the FOCUSfactor brand name; and lifestyle and wellness products and accessories, including tea, shakes, lollipops, supplements, apparel, and exercise accessories under the Flat Tummy brand name. The company also provides hand care products under the Hand MD brand name; beauty products for the eyes, lips, brows, cheeks, and skin under the Perfekt Beauty brand; shapewear, bralettes, and panties under Sneaky Vaunt brand; eyelash enhancement products under The Queen Pegasus brand; topical treatments for neuropathic pain under Neuragen brand; and over-the-counter medications under UrgentRx brand. It sells its products through club, mass drug, and other retailers. The company was formerly known as Synergy Strips Corp. and changed its name to Synergy CHC Corp.
Track the progress of the S&P 500 stocks to make more informed investment decisions.
See our picks for the best brokers for trading S&P 500 stocks, ETFs, options and futures.
These are the stocks to buy when you don’t have much to spend.
Explore the best bonuses for opening a new brokerage account.
Stock lending allows investors to loan out their existing stocks, although it has both advantages and disadvantages.
Compare pros, cons, research tools and reviews for these two trading platforms.
Some of the best trading apps like Robinhood are SoFi, Tastytrade, Public, eToro, Acorns, Interactive Brokers, E*TRADE and more.
Compare pros, cons, research tools and reviews for these two trading platforms.
SoFi Invest is a no-fee commissions platform with both active and automated investment accounts.
Webull is a broker with zero-commission trading and a suite of tools to help you invest.